Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 1, 1999, Pages 8-14

  Baldini, Elizabeth H ^a   DeCamp Jr , Malcolm M ^a   Katz, Matthew S ^a   Berman, Stuart M ^a   Swanson, Scott J ^a   Mentzer, Stephen J ^a   Bueno, Raphael ^a   Sugarbaker, David J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adjuvant radiation therapy; Clinical stage II non small cell lung cancer; Patterns of recurrence; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033494778     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199902000-00003     Document Type: Article

References (18)

1. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-33S.
2. Mountain CF. Assessment of the role of surgery for control of lung cancer. Ann Surg 1977;24:365-73.
3. Naruke T, Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-7.
4. Gradishar WJ, Mick R, Hoffman PC, et al. The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol 1992;15:405-11
5. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1986;315:1377-81.
6. Chung CK, Stryker JA, O'Neill M, et al. Evaluation of adjuvant postoperative radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1982;8:1877-80.
7. Green N, Kurohara SS, George FW, et al. Postresection irradiation for primary lung cancer. Radiology 1975;116:405-7.
8. Martini N, Flehinger BJ, Nagasaki F, et al. Prognostic significance of N1 disease in carcinoma of the lung. J Thorac Cardiovasc Surg 1983;86:646-53.
9. Choi NCH, Grillo HC, Gardiello M, et al. Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1980;6:31-5.
10. Kaplan E, Meier P. Non parametric estimation from incomplete observations. Journal of the American Statistical Association 1958;53:457-81.
11. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized trials requiring observation of each patient: II. analysis and examples. Br J Cancer 1977;35:1-39.
12. Nixon AJ, Recht A, Neuberg D, et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys 1994;30:17-21.
13. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987;59:1874-81.
14. Cox JD, Azarina N, Byhardt RW, et al. A randomized phase I/1I trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with <69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung cancer, report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8:1543-55.
15. Schaake-Koning C, Schuster-Uitterhoeve L, Hart G, et al. Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy. Int J Radial Oncol Biol Phys 1983;9:1023-8.
16. Kodama T, Nishiyama H, Nishiwaki Y. Histology and prognosis in lung cancer treatment. Nippon Kyobu Shikkan Gakkai Zasshi 1990;28:216-24.
17. Brownson RC, Chang JL, Davis JR. Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology 1992;3:61-4.
18. Ries LA. Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data. Semin Surg Oncol 1994;10:21-30.